The NKTR (Nektar Therapeutics) Active Short Trade hit T1 for a 15.2% profit on Friday, in less than 3 weeks since entry, with the expected reaction of T1 occuring so far today. The maximum suggested stop for those targeting the final target, T2 at 73.89, remains any move above 121.00 although the stock has a fairly well-defined & technically significant resistance level (orange line) around 109-110 in which one could set a more aggressive stop slightly above to increase the R/R on a position targeting the second & final price target. A bounce to that level might also provide another objective short entry for those that booked profits at T1. As of now, factoring in my near-term bullish outlook for the broad market coupled with the expected bounce off the initial tag of T1, I would say a test of that resistance zone is likely at this time.  Previous & updated daily charts: